Keep God Weird

Tuesday, April 15, 2008

Market Report -- In Play (ABII)

Abraxis life science denotes determinations propose ABRAXANE Avastin combination defeats newly discovered phenomenon of reactionist angiogenesis Carbon Dioxide presented presymptomatic information demonstrating the consequence of ABRAXANE for Injectable Suspension in combination with Avastin (DNA) to eliminate large-sized (up to 600 mm3) orthotopic breast tumours and lymphatic and systematic metastasis at the American Association for Cancer Research Annual Meeting held April 12-16, 2008 in San Diego, California. The determinations presented at A.A.C.R propose a novel chemical mechanism through which ABRAXANE can defeat a newly discovered phenomenon of reactionist angiogenesis. These consequences corroborate a synergistic consequence of ABRAXANE and Avastin combination on metastasis in breast malignant neoplastic disease previously presented orally at the San Antonio Breast Cancer Symposium in December 2007. After treatment with two rhythms of ABRAXANE and Avastin given concurrently at 30 mg/kg and 4 mg/kg, respectively, 100% of pre-clinical exemplaries were free of metastasis in lymph nodes and lungs as determined by measurement luciferase activity and complete arrested developments of the big orthotopic primary election MDA-MB-231-Luc+ tumours were achieved.

is the prima Internet supplier of unrecorded marketplace analysis for U.S. Stock, U.S. Bond, and human race FX marketplace participants.

Read more articles

advertisement

Labels: , , , , , , , , , ,


Comments: Post a Comment



<< Home

Digg ItDel.icio.us
Furl ItReddit
My WebNewsvine
WistsBlogmarks
RSS ATOM
Web Pages referring to this page
Link to this page and get a link back!

Archives

June 2007 September 2007 November 2007 December 2007 January 2008 February 2008 March 2008 April 2008 May 2008 September 2008 October 2008 November 2008 December 2008 January 2009 February 2009 March 2009 September 2009 October 2009

This page is powered by Blogger. Isn't yours?